Fig. 1

Kaplan–Meier survival curves for OS and PFS. (Α, Β) Kaplan–Meier curves of the pembrolizumab-containing regimen for OS (A) and PFS (B). Pembrolizumab-containing regimens included both pembrolizumab with chemotherapy and pembrolizumab alone. OS: overall survival; PFS: progression-free survival.